It is well known that PIK3CAan, oncogene encoding the p110a catalytic subunit of the phosphoinositide 3-kinase (PI3K), is frequently overexpressed in malignant tumors, which induce the aberrant activation of the PI3K/AKT signaling pathway24. Here, AKT1 is linked to cancer.